Tag Archive | "head and neck cancer"

Expanded age indication cleared for Gardasil 9 in males

Wednesday, December 30, 2015

0 Comments

Source: www.FormularyJournal.ModernMedicine.com Author: Erin Bastick   FDA approved an expanded age indication for Human Papillomavirus 9-valent Vaccine, Recombinant (Gardasil 9, Merck) in males. Seven HPV types in Gardasil 9 (HPV 16, 18, 31, 33, 45, 52, and 58) cause approximately 90% to 95% of HPV-related anal cancers, 90% of cervical cancers, and 80% of high-grade […]

Continue reading...

Depressed Head and Neck Cancer Patients Have Lower Survival and Higher Recurrence Risk

Wednesday, December 30, 2015

0 Comments

Source: www.OncologyNurseAdvisor.com Author: Kathy Boltz, PhD   Depression is a significant predictor of 5-year survival and recurrence in patients with head and neck cancer, according to a new study published in Pyschosomatic Medicine (doi: 10.1097/PSY.0000000000000256). These findings represent one of the largest studies to report on the impact of depression on cancer survival. Although depression […]

Continue reading...

Head, Neck Cancer Patients May Be at Higher Risk for Suicide: Study

Friday, November 13, 2015

0 Comments

Source: www.health.usnews.com Author: Robert Preidt   THURSDAY, Nov. 12, 2015 (HealthDay News) — Head and neck cancer patients may be at raised risk for suicide, new research suggests. However, the overall risk is still small, the findings showed. The study included over 350,000 patients in the United States diagnosed with head and neck cancer between […]

Continue reading...

Why groundbreaking new cancer drugs still don’t work for most patients

Friday, October 30, 2015

0 Comments

Source: www.news.doximity.com Author: Brady Dennis Immunotherapy, which aims to harness the body’s immune system to fight off certain cancers, has received plenty of attention, praise and investment in recent years. Breakthrough treatments for melanoma and other cancers have shown startling results, giving some patients months and often years of life they almost certainly would not otherwise have had. Yet, for […]

Continue reading...

Less Is More for HPV Oropharyngeal Cancer Reduced-intensity regimen clears disease in 86% of cases

Wednesday, October 21, 2015

0 Comments

Source: www.medpagetoday.com Author: Charles Bankhead   SAN ANTONIO — Less intense treatment of low-risk human papillomavirus (HPV)-related oropharyngeal cancer achieved a high rate of pathologic complete response (pCR) and favorable patient-reported outcomes, a preliminary trial showed. Overall, 37 of 43 (86%) patients achieved pCR with deintensified chemoradiation, including all but one evaluable primary tumor. The […]

Continue reading...

SA Developed Melanoma Drug Now Seen Effective in Fighting Lung Cancer

Tuesday, October 6, 2015

0 Comments

Source: www.woai.com Author: News Radio 1200 WOAI Staff   Keytruda, a cancer drug developed largely at San Antonio’s START Center, has already proven to be effective in treating advanced melanoma to the point that it is the major part of former President Jimmy Carter’s treatment.  Now, News Radio 1200 WOAI reports Keytruda has been given […]

Continue reading...

Patient Support in Oral Cancer: From Sydney to New York to London, survivors and patients interact through an important portal to get through difficult times

Tuesday, September 29, 2015

0 Comments

Source: www.prnewswire.com Author: Press Release   NEWPORT BEACH, Calif., Sept. 28, 2015 — The word “cancer” will incite fear in anyone. When that word comes at the end of a sentence that began with your name, the impact can be life changing. “I had a great job, a beautiful house and a happy family life,” recalls […]

Continue reading...

FDA Grant Forwards Listeria-Based Throat Cancer Vaccine

Thursday, September 17, 2015

0 Comments

Source: www.targetedonc.com Author: Sandra Kear   An experimental immunotherapy for human papillomavirus-, or HPV-, related throat cancers, which is driven by the Listeria bacteria (that wreaks havoc when ingested), may now move forward due to a $1.1 million dollar grant from the FDA to researchers at Baylor College of Medicine.   “Immunotherapy, such as axalimogene […]

Continue reading...

AstraZenica, Inovio strike deal to find HPV cancer vaccine

Monday, August 10, 2015

0 Comments

Source: www.philly.com Author: David Sell   Local drugmakers – big and small – struck a deal to try to develop a vaccine to prevent a form of cervical, head and neck cancer.  MedImmune, which is the biologics and research division with AstraZeneca, said Monday it will collaborate with Inovio Pharmaceuticals to develop an early stage […]

Continue reading...

Testimony by otolaryngologists in defense of tobacco companies 2009–2014

Friday, July 31, 2015

0 Comments

Source: www.onlinelibrary.wiley.com Author: Robert K. Jackler, MD   Abstract Objectives/Hypothesis To examine expert testimony offered by otolaryngologists in defense of the tobacco industry and to assess whether opinions rendered were congruent with evidence in the scientific literature. Methods Data sources include publically available expert witness depositions and trial testimony of board-certified otolaryngologists employed by the […]

Continue reading...